New Notices
- New Notice of Intent to Revise: Dextrose Injection (posted 15–Oct–2021)
- New Notice of Intent to Revise: Glucagon (posted 01–Oct–2021)
- New General Announcement: New General Chapter <1220> Analytical Procedure Life Cycle (posted 24–Sep–2021)
- New General Chapter Prospectus: <2760> Impurities in Dietary Ingredients and Dietary Supplements (posted 24–Sep–2021; input deadline 24–Oct–2021)
- New Notice of Intent to Revise: <795> Pharmaceutical Compounding—Nonsterile Preparations (posted 01–Sep–2021)
- New Notice of Intent to Revise: <797> Pharmaceutical Compounding— Sterile Preparations (posted 01–Sep–2021)
- New Notice of Intent to Revise: Bifidobacterium bifidium (posted 27–Aug–2021)
- New Notice of Intent to Revise: Bifidobacterium longum subsp. longum (posted 27–Aug–2021)
- New Notice of Intent to Revise: Lactobacillus reuteri (posted 27–Aug–2021)
- New Notice of Intent to Revise: Lactobacillus rhamnosus (posted 27–Aug–2021)
- New Notice of Intent to Revise: Magnesium Family of Monographs (posted 27–Aug–2021)
- New General Announcement: USP Virtual Roundtable on Reporting Thresholds in Monographs (held on June 29, 2021) (posted 27–Aug–2021)
- New Notice of Intent to Revise: Dextran 40 (posted 30–Jul–2021)
- New Notice of Intent to Revise: Dextran 70 (posted 30–Jul–2021)
- New Notice of Intent to Revise: Mesalamine Delayed-Release Tablets (posted 30–Jul–2021)
- Notice of Intent to Revise: Monographs with Postponed Content (posted 30–Jul–2021)
- New Notice of Intent to Revise: Rotigotine (posted 30–Jul–2021)
- New Notice of Intent to Revise: Technetium Tc 99m Monographs: Removal of Biological Tests (posted 30–Jul–2021)